Literature DB >> 8438608

Epidemiology of diarrhoeal disease: implications for control by vaccines.

R E Black1.   

Abstract

Vaccines present perhaps the most attractive solution to the worldwide problem of diarrhoeal disease. Epidemiological evidence has important implications for the development and use of such vaccines, and results of studies on diarrhoeal diseases in developing and developed countries, in particular among children, and travellers' diarrhoea are reviewed. The virulence and pathogenicity of various enteropathogens are discussed, and the extent to which immunity may be acquired. It is concluded that the development of appropriate vaccines may be a complex task.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8438608     DOI: 10.1016/0264-410x(93)90002-f

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  52 in total

1.  Beyond serotypes and virulence-associated factors: detection of genetic diversity among O153:H45 CFA/I heat-stable enterotoxigenic Escherichia coli strains.

Authors:  A B Pacheco; L C Ferreira; M G Pichel; D F Almeida; N Binsztein; G I Viboud
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Type IV longus pilus of enterotoxigenic Escherichia coli: occurrence and association with toxin types and colonization factors among strains isolated in Argentina.

Authors:  Mariana G Pichel; Norma Binsztein; Firdausi Qadri; Jorge A Girón
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Identification and characterization of CS20, a new putative colonization factor of enterotoxigenic Escherichia coli.

Authors:  H Valvatne; H Sommerfelt; W Gaastra; M K Bhan; H M Grewal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Synergistic Killing of Pathogenic Escherichia coli Using Camel Lactoferrin from Different Saudi Camel Clans and Various Antibiotics.

Authors:  Hussein A Almehdar; Nawal Abd El-Baky; Abdulqader A Alhaider; Saud A Almuhaideb; Abdullah A Alhaider; Raed S Albiheyri; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

5.  The pCoo plasmid of enterotoxigenic Escherichia coli is a mosaic cointegrate.

Authors:  Barbara Froehlich; Julian Parkhill; Mandy Sanders; Michael A Quail; June R Scott
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

6.  Gas phase characterization of the noncovalent quaternary structure of cholera toxin and the cholera toxin B subunit pentamer.

Authors:  Jonathan P Williams; Daniel C Smith; Brian N Green; Brian D Marsden; Keith R Jennings; Lynne M Roberts; James H Scrivens
Journal:  Biophys J       Date:  2006-02-03       Impact factor: 4.033

7.  PCR-based identification of common colonization factor antigens of enterotoxigenic Escherichia coli.

Authors:  Abhisek Ghosal; Rudra Bhowmick; Ranjan Kumar Nandy; T Ramamurthy; Nabendu Sekhar Chatterjee
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

Review 8.  Virulence regulons of enterotoxigenic Escherichia coli.

Authors:  George P Munson
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

9.  A descriptive review of selected nonviral enteric illnesses reported in children in Quebec between 1999 and 2006.

Authors:  Henri Kaboré; Pascal Michel; Patrick Levallois; Pierre Déry; Pierre Payment; Germain Lebel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

10.  Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge.

Authors:  Sergio Rosales-Mendoza; Ruth Elena Soria-Guerra; Rubén López-Revilla; Leticia Moreno-Fierros; Angel Gabriel Alpuche-Solís
Journal:  Plant Cell Rep       Date:  2007-09-15       Impact factor: 4.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.